insights_auto
Why is DEVA down २.२९%?
Dive Deeperchevron_right
DEVA:IST
Deva Holding AS
TRY ७९.१०
arrow_downward
-२.२९%(-१.८५) 1D
अक्टोबर १४, १२:४९:५२ GMT+३ · TRY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DEVA...
Open
TRY ८०.८०
High
TRY ८०.८०
Low
TRY ७८.६०
Mkt. cap
१५.८२ अरब
Avg. vol.
६.३५ लाख
Volume
१.७१ लाख
52-wk high
TRY १०९.३०
52-wk low
TRY ५७.५०
EPS
-TRY ४.२१
Shares outstanding
२०.०० करोड
No. of employees
३ हजार
Open
TRY ८०.८०
High
TRY ८०.८०
Low
TRY ७८.६०
Mkt. cap
१५.८२ अरब
Avg. vol.
६.३५ लाख
Volume
१.७१ लाख
52-wk high
TRY १०९.३०
52-wk low
TRY ५७.५०
EPS
-TRY ४.२१
Shares outstanding
२०.०० करोड
No. of employees
३ हजार
News stories
From web sources and news partners
GlobeNewswire
·
११ मिनेट पहिले
Owlting Group (NASDAQ: OWLS) and Decaf Open U.S. Dollar Accounts Beyond the United States on OwlPay Harbor
StockStory
·
३९ मिनेट पहिले
1 S&P 500 Stock with Competitive Advantages and 2 We Brush Off
Investor's Business Daily
·
४० मिनेट पहिले
Dow Futures Rise; ASML Earnings Beat, CPI Inflation Due
Seeking Alpha
·
२ घण्टा पहिले
Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS